Show simple item record

dc.contributor.authorMcKetin, Rebecca
dc.contributor.authorQuinn, B.
dc.contributor.authorHiggs, Peter
dc.contributor.authorBerk, M.
dc.contributor.authorDean, O.M.
dc.contributor.authorTurner, A.
dc.contributor.authorKelly, P.J.
dc.contributor.authorLubman, D.I.
dc.contributor.authorCarter, G.
dc.contributor.authorBaker, A.L.
dc.contributor.authorManning, V.
dc.contributor.authorThomas, T.
dc.contributor.authorBathish, R.
dc.contributor.authorRaftery, D.
dc.contributor.authorSaunders, L.
dc.contributor.authorWrobel, A.
dc.contributor.authorMeehan, A.
dc.contributor.authorSinclair, B.
dc.contributor.authorReid, D.
dc.contributor.authorArunogiri, S.
dc.contributor.authorHill, H.
dc.contributor.authorCordaro, F.
dc.contributor.authorDietze, Paul
dc.date.accessioned2023-04-13T08:50:42Z
dc.date.available2023-04-13T08:50:42Z
dc.date.issued2021
dc.identifier.citationMcKetin, R. and Quinn, B. and Higgs, P. and Berk, M. and Dean, O.M. and Turner, A. and Kelly, P.J. et al. 2021. Clinical and demographic characteristics of people who smoke versus inject crystalline methamphetamine in Australia: Findings from a pharmacotherapy trial. Drug and Alcohol Review. 40 (7): pp. 1249-1255.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/91412
dc.identifier.doi10.1111/dar.13183
dc.description.abstract

Introduction and Aims: There has been a rapid increase in smoking crystalline methamphetamine in Australia. We compare the clinical and demographic characteristics of those who smoke versus inject the drug in a cohort of people who use methamphetamine. Design and Methods: Participants (N = 151) were dependent on methamphetamine, aged 18–60 years, enrolled in a pharmacotherapy trial for methamphetamine dependence, and reported either injecting (n = 54) or smoking (n = 97) methamphetamine. Measures included the Timeline Followback, Severity of Dependence Scale, Amphetamine Withdrawal Questionnaire, Craving Experience Questionnaire and the Brief Psychiatric Rating Scale (symptoms of depression, hostility, psychosis and suicidality). Simultaneous regression was used to identify independent demographic correlates of smoking methamphetamine and to compare the clinical characteristics of participants who smoked versus injected. Results: Compared to participants who injected methamphetamine, those who smoked methamphetamine were younger and less likely to be unemployed, have a prison history or live alone. Participants who smoked methamphetamine used methamphetamine on more days in the past 4 weeks than participants who injected methamphetamine (26 vs. 19 days, P = 0.001); they did not differ significantly in their severity of methamphetamine dependence, withdrawal, craving or psychiatric symptoms (P > 0.05). After adjustment for demographic differences, participants who smoked had lower craving [b (SE) = −1.1 (0.5), P = 0.021] and were less likely to report psychotic symptoms [b (SE) = −1.8 (0.7), P = 0.013] or antidepressant use [b (SE) = −1.1 (0.5), P = 0.022]. Discussion and Conclusions: Smoking crystalline methamphetamine is associated with a younger less marginalised demographic profile than injecting methamphetamine, but a similarly severe clinical profile.

dc.languageEnglish
dc.publisherWILEY
dc.relation.sponsoredbyhttp://purl.org/au-research/grants/nhmrc/1128147
dc.relation.sponsoredbyhttp://purl.org/au-research/grants/nhmrc/1135901
dc.relation.sponsoredbyhttp://purl.org/au-research/grants/nhmrc/1136908
dc.relation.sponsoredbyhttp://purl.org/au-research/grants/nhmrc/1156072
dc.relation.sponsoredbyhttp://purl.org/au-research/grants/nhmrc/1145634
dc.relation.sponsoredbyhttp://purl.org/au-research/grants/nhmrc/1059660
dc.subjectScience & Technology
dc.subjectLife Sciences & Biomedicine
dc.subjectSubstance Abuse
dc.subjectmethamphetamine
dc.subjectpharmacotherapy
dc.subjectcharacteristics
dc.subjectinject
dc.subjectsmoke
dc.subjectPSYCHOMETRIC PROPERTIES
dc.subjectDRUG-USE
dc.subjectHARMS
dc.subjectUSERS
dc.subjectDEPENDENCE
dc.subjectSEVERITY
dc.subjectCOCAINE
dc.subjectHEROIN
dc.subjectcharacteristics
dc.subjectinject
dc.subjectmethamphetamine
dc.subjectpharmacotherapy
dc.subjectsmoke
dc.subjectAdolescent
dc.subjectAdult
dc.subjectAmphetamine-Related Disorders
dc.subjectAustralia
dc.subjectCentral Nervous System Stimulants
dc.subjectDemography
dc.subjectHumans
dc.subjectMethamphetamine
dc.subjectMiddle Aged
dc.subjectSmoking
dc.subjectYoung Adult
dc.subjectHumans
dc.subjectAmphetamine-Related Disorders
dc.subjectMethamphetamine
dc.subjectCentral Nervous System Stimulants
dc.subjectSmoking
dc.subjectDemography
dc.subjectAdolescent
dc.subjectAdult
dc.subjectMiddle Aged
dc.subjectAustralia
dc.subjectYoung Adult
dc.titleClinical and demographic characteristics of people who smoke versus inject crystalline methamphetamine in Australia: Findings from a pharmacotherapy trial
dc.typeJournal Article
dcterms.source.volume40
dcterms.source.number7
dcterms.source.startPage1249
dcterms.source.endPage1255
dcterms.source.issn0959-5236
dcterms.source.titleDrug and Alcohol Review
dc.date.updated2023-04-13T08:50:42Z
curtin.departmentEnAble Institute
curtin.accessStatusOpen access
curtin.facultyFaculty of Health Sciences
curtin.contributor.orcidDietze, Paul [0000-0001-7871-6234]
dcterms.source.eissn1465-3362
curtin.contributor.scopusauthoridHiggs, Peter [7006359929]
curtin.contributor.scopusauthoridMcKetin, Rebecca [6602587507]
curtin.repositoryagreementV3


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record